Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibody

被引:11
|
作者
Wang, BY
Berger, M
Masters, G
Albone, E
Yang, QF
Sheedy, J
Kirksey, Y
Grimm, L
Wang, B
Singleton, J
Soltis, D
机构
[1] BioRexis Pharmaceut Corp, King Of Prussia, PA 19406 USA
[2] Purdue Pharma LP, Dept Immunotherapeut, Cranbury, NJ USA
关键词
tissue factor; NSCLC; antibody; radioimmunotherapy; yttrium;
D O I
10.1089/cbr.2005.20.300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue factor (TF) is a type I transmembrane protein and the initiator of the extrinsic blood coagulation pathway. TF plays a critical role in tumor development and its overexpression is observed in many tumors. To understand the prevalence and relative level of TF expression in non-small-cell lung cancer (NSCLC), we analyzed 50 NSCLC tumors by immunohistochemical staining and found that 88% of human NSCLC tumors overexpressed TF. We then generated a high affinity anti-TF antibody, TF278, which specifically binds TF on the surface of cells and is internalized upon binding. An In-111-labeled TF278 demonstratedfavorable tumor accumulation in an SW-900 xenograft tumor model with a maximum mean percent of injected dose per gram of tissue (%ID/g) of 73.1% at 96 hours postinjection. In addition, we labeled the antibody with Y-90 and tested its ability to inhibit the growth of tumors in an SW-900 xenograft tumor model in immunocompromised mice. The Y-90-TF278 slowed the growth of SW-900 tumors at a 50 mu Ci dose and completely regressed SW-900 tumors at a 150 mu Ci dose with little toxicity.
引用
收藏
页码:300 / 309
页数:10
相关论文
共 50 条
  • [1] Radioimmunotherapy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody
    Vallera, DA
    Brechbiel, MW
    Burns, LJ
    Panoskaltsis-Mortari, A
    Dusenbery, KE
    Clohisy, DR
    Vitetta, ES
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7920 - 7928
  • [2] Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody
    Aung, Winn
    Tsuji, Atsushi B.
    Sudo, Hitomi
    Sugyo, Aya
    Ukai, Yoshinori
    Kouda, Katsushi
    Kurosawa, Yoshikazu
    Furukawa, Takako
    Saga, Tsuneo
    [J]. ONCOTARGET, 2016, 7 (25) : 38835 - 38844
  • [3] Fractionated Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CEA Antibody
    Hanaoka, Hirofumi
    Kuroki, Masahide
    Yamaguchi, Aiko
    Achmad, Arifudin
    Iida, Yasuhiko
    Higuchi, Tetsuya
    Oriuchi, Noboru
    Tsushima, Yoshito
    Endo, Keigo
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2014, 29 (02) : 70 - 76
  • [4] 86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics
    Ferreira, Carolina A.
    Ehlerding, Emily B.
    Rosenkrans, Zachary T.
    Jiang, Dawei
    Sun, Tuanwei
    Aluicio-Sarduy, Eduardo
    Engle, Jonathan W.
    Ni, Dalong
    Cai, Weibo
    [J]. MOLECULAR PHARMACEUTICS, 2020, 17 (05) : 1697 - 1705
  • [5] Tissue factor as an anti-cancer target: Anti-tissue factor monoclonal antibody inhibits tumor growth and metastasis in nude mice.
    Wen, JH
    Wong, HC
    Jiao, JA
    [J]. BLOOD, 2003, 102 (11) : 809A - 809A
  • [6] Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice
    Verel, I
    Visser, GWM
    Boellaard, R
    Boerman, OC
    van Eerd, J
    Snow, GB
    Lammertsma, AA
    van Dongen, GAMS
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (10) : 1663 - 1670
  • [7] Radiotherapy of CD19 expressing Daudi tumors in nude mice with yttrium-90-labeled anti-CD19 antibody
    Vallera, DA
    Elson, M
    Brechbiel, MW
    Dusenbery, KE
    Burns, LJ
    Jaszcz, WB
    Ramsay, NK
    Panoskaltsis-Mortar, A
    Kuroki, DW
    Wagner, JE
    Vitetta, ES
    Kersey, JH
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (01) : 11 - 23
  • [8] Targeted radiotherapy of integrin αvβ3-positive tumors with 90Y-labeled RGD tetramer
    Jia, Bing
    Yu, Zilin
    Liu, Zhaofei
    Shi, Jiyun
    Zhao, Huiyun
    Chen, Xiaoyuan
    Wang, Fan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [9] Human immune cell infiltration of tumors in a PBMC-humanized NSG mouse xenograft model changes with treatment of an anti-tissue factor antibody
    Millar-Quinn, Hillary
    Hertzog, Brenda
    Hanson, Rebecca
    Nemeth, Jeffrey
    Alvarez, John
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] Radiotherapy of CD45-expressing daudi tumors in nude mice with yttrium-90-labeled, PEGylated Anti-CD45 antibody
    Vallera, Daniel A.
    Sicheneder, Andy R.
    Taras, Elizabeth P.
    Brechbiel, Martin W.
    Vallera, Jesse A.
    Panoskaltsis-Mortari, Angela
    Burns, Linda J.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (04) : 488 - 500